KR101879940B1 - Pilot Bio-Signal Monitoring System using Wearable Continuous Body Fluid checking apparatus - Google Patents

Abstract

The present invention relates to a system for detecting a bio-signal of a pilot using a wearable continuous body fluid check system, which comprises a body fluid sensor 110 configured to be worn by a user and configured to include a probe sensor partially inserted into the user's skin, A blood glucose measuring unit 120 for continuously measuring the blood glucose level in the body fluid provided through the body fluid sensor 110 and a controller 120 for determining whether the blood glucose level measured by the blood glucose measuring unit 120 is out of a normal range And a main controller 140 for displaying a warning through the warning unit 150 and for informing the wireless communication interface 160 of the abnormality of the blood glucose level when the blood glucose level is out of the normal range, (100) which is installed in the vehicle and which is connected to the wireless communication interface (210) And a driving means control unit (230) for receiving the occurrence of the abnormal blood glucose condition from the new interface (160). (10) for detecting a bio-signal of a pilot using a wearable continuous body fluid check system.

Description

[0001] The present invention relates to a pilot bio-signal monitoring system using a wearable continuous fluid check system,

The present invention relates to a system for detecting a bio-signal of a pilot using a wearable continuous body fluid check system, which comprises a body fluid sensor 110 configured to be worn by a user and configured to include a probe sensor partially inserted into the user's skin, A blood glucose measuring unit 120 for continuously measuring the blood glucose level in the body fluid provided through the body fluid sensor 110 and a controller 120 for determining whether the blood glucose level measured by the blood glucose measuring unit 120 is out of a normal range And a main controller 140 for displaying a warning through the warning unit 150 and for informing the wireless communication interface 160 of the abnormality of the blood glucose level when the blood glucose level is out of the normal range, (100) which is installed in the vehicle and which is connected to the wireless communication interface (210) And a driving means control unit (230) for receiving the occurrence of the abnormal blood glucose condition from the new interface (160). (10) for detecting a bio-signal of a pilot using a wearable continuous body fluid check system.

In the case of large vehicles such as airplanes, railways, buses or ships, pilots (usually called engineers / drivers in the case of railways or buses, or sailors in the case of ships) ') Can be subjected to various abnormal circumstances. Sometimes, in a rapidly changing environment or in an emergency environment, large maneuvers such as aircraft must be controlled, and sudden changes may occur in the pilot's living condition. The maintenance status of the aircraft itself is also important for the safe operation of the means of operation, but the life state of the pilot who manages the means of operation is also very important.

In order to measure the living state of such a pilot, a safety accident prevention device using a bio-signal or flight pattern of an airplane pilot (Korean Patent No. 10-1109514) of the following Patent Document 1 has conventionally been applied to a neck support of a cockpit And a second electrocardiograph sensor provided on the neck support and measuring a first electrocardiogram signal of the pilot in contact with the neck during sitting of the pilot, wherein the first electrocardiogram sensor is mounted on the neck support and measures a pulse wave of the pilot, A second electrocardiogram sensor provided in a stick type input device for piloting an aircraft and measuring a second electrocardiogram signal of the pilot in contact with the hand when the pilot grasps the stick type input device by hand, The measured pulse wave, the first electrocardiogram signal, and the second electrocardiogram signal were analyzed, and as a result of analysis, an abnormality occurred in the body of the pilot And a warning signal generating unit for generating a warning signal when it is judged.

However, in the existing invention, when the bio-signal of the pilot is merely a pulse / electrocardiogram, it is determined that the pilot has already been unable to steer if it is determined that the abnormality has occurred. Therefore, There was a problem.

In addition, there has been a problem in that continuous measurement can not be performed due to a change in attitude of the pilot due to the limitation that the means for measuring the bio-signal of the pilot is installed in the neck support of the seat and the stick type input device.

Unlike the pulse or electrocardiogram described above, some of the bio-signals of the pilot can be predicted to some extent and preventive measures can be taken. There are factors related to abnormality of the pilot's blood glucose such as hypoglycemic state.

Hypoglycemia refers to a state in which blood sugar is lower than in normal people. Generally speaking, when blood sugar is below 50 mg / dl, the symptoms are lack of aura, trembling of the body, pale, cold sweats, dizziness, excitement, anxiety, There are numbness, hunger, headache and fatigue. Long-lasting hypoglycemia can lead to seizures or seizures, resulting in shock conditions and loss of consciousness, and can lead to fatal conditions in the pilot's condition and operational safety. Such hypoglycemic symptoms can be caused by a variety of causes, such as diabetes mellitus or adrenal insufficiency, which have been rapidly increasing in recent years. On the other hand, such hypoglycemia can be rapidly recovered by consuming foods (candy / juice / sugar) that can rapidly raise blood sugar, so it may be effective to measure and cope with the drop in blood glucose level in advance.

To continuously measure such blood glucose, a number of continuous glucose monitoring (CGM) systems have recently been proposed. Regarding this conventional continuous blood glucose measurement system, the following Patent Document 2 or Patent Document 3 discloses a blood glucose measuring sensor including a needle inserted into a user's skin as a sensor capable of continuously monitoring the blood glucose level in the body, A continuous blood glucose monitoring sensor based on a nanostructure for electrochemistry and capable of biocompatibility by a means for improving biocompatibility, including a membrane structure in which interference is removed by using a selective permeability on the surface .

However, in the configuration disclosed in the existing invention relating to the continuous blood glucose measurement system, a configuration in which a needle is inserted into a user's body has been disclosed. However, in the case of using a conventional needle of a rigid material, If the sensor needs to be worn at all times for continuous blood glucose measurement, it is necessary to secure the length of the needle necessary for maintaining the predetermined insertion state required, such as "b" There is a problem in that it is impossible to measure the blood glucose effectively because the needle is inserted into the muscle layer (M) for a long time through the subcutaneous (S) where the needle of the sensor should be located for actually measuring the blood sugar.

In order to solve such a problem, in order to maintain the inserted state of the needle into the user's body, when the needle of the inserted needle forms a short needle having a length reaching only the subcutaneous S, There arises a new problem that it must be fixed by using external fixing means, and it also causes a foreign body feeling and pain to the user, which makes it difficult to wear and carry at all times.

On the other hand, another risk factor that can cause a dangerous situation during the operation is the increase of blood alcohol concentration due to the drunkenness of the pilot. The increase in alcohol concentration due to alcohol causes an extremely dangerous situation in the operation of all means of transportation, such as deterioration of judgment ability and reaction speed. It is strictly prohibited to fly or operate under high alcohol concentration by law or regulation. . However, there is a problem that the measurement of the blood alcohol concentration is performed once or selectively, such as before the flight or when the vehicle is checked, and it is impossible to continuously and effectively measure the operation of the vehicle.

1. Korean Patent No. 10-1109514 2. Korean Patent No. 10-1512566 3. Korean Patent No. 10-1454278

SUMMARY OF THE INVENTION The present invention has been made to solve the above problems of the prior art and provides a pilot bio-signal detection system using a wearable continuous blood glucose check system in which a pilot can easily wear the bio- A bio-signal abnormality of a pilot such as blood sugar or blood alcohol concentration is continuously checked to detect the occurrence of an abnormal situation beforehand, and a quick and preventive countermeasure can be made through warning or the like.

In order to make accurate measurement, the tip of the flexible probe sensor is positioned in subcutaneous (S) by sequentially passing epidemis (E) and dermis (D) of the user's skin in an oblique direction Thus, it is an object of the present invention to enable efficient and accurate measurement, and also to prevent the user from feeling a foreign body or pain while maintaining the inserted state in the user's body without any external fixing means.

On the other hand, for more precise measurement, it is possible to measure more precisely with shallow penetration depth by using carbon nanotube (CNT) hybrid sensor electrode on which boron doped diamond (BDD: Boron Doped Diamond) is fixed on the surface As a matter of course, it is a task to increase the convenience of the user.

According to an aspect of the present invention, there is provided a system for detecting a bio-signal of a pilot using a wearable continuous body fluid check system according to an embodiment of the present invention includes a probe sensor, A blood glucose measurement unit 120 for continuously measuring the blood glucose level in the body fluid provided through the body fluid sensor 110, a blood glucose measurement unit 120 for measuring the blood glucose level measured by the blood glucose measurement unit 120, If the blood glucose level is out of the normal range, a warning is displayed through the warning unit 150, and the wireless communication interface 160 determines whether the blood glucose abnormality is present And a control unit 140 installed in the driving means and configured to communicate with the driving means wireless communication interface 210 And a driving means control unit (230) for receiving the occurrence of the abnormality in blood glucose status from the wireless communication interface (160) through wireless communication through the wireless communication interface (160). And a control unit.

The wearable continuous body fluid check system 100 further includes an in-body alcohol concentration measuring unit 130 for continuously measuring blood alcohol concentration in the body fluid provided through the body fluid sensor 110, If it is determined that the blood alcohol concentration measured by the in-vivo alcohol concentration measuring unit 130 is equal to or higher than the reference value, the main control unit 140 displays a warning through the warning unit 150, 160) is further informed of whether or not the alcohol concentration is abnormal.

The wearable continuous fluid check system 100 may further include at least one of an electrocardiogram sensor 170 capable of measuring the electrocardiogram of the user or a pulse sensor 180 measuring the heartbeat vibration of the user And the main controller 140 analyzes the electrocardiogram signal or the pulse signal measured by the electrocardiogram sensor 170 or the pulse sensor 180. When it is determined that the electrocardiogram or heartbeat abnormality is present, And transmits the warning to the wireless communication interface 160 whether the ECG or heartbeat abnormality is present.

The driving means system 200 includes a driving means communication unit 220 for transmitting the abnormal situation occurrence received from the driving means control unit 230 to the control server 300 through a communication network; And further comprising:

In addition, the driving means system 200 may include an automatic control device 240 that automatically controls the driving means under the control of the driving means control unit 230 when the abnormal situation occurs, The emergency operation device 250, and the emergency operation device 250 according to the present invention.

The body fluid sensor 110 is composed of a flexible probe sensor made of a material having elasticity and the flexible probe sensor is configured to detect an epidemis E and a dermis D of a user in a diagonal direction And the distal end of the flexible probe sensor is positioned in the subcutaneous tissue S, wherein the flexible probe sensor has a curved shape with a predetermined curvature toward the outside when inserted into the user's skin And is formed so as to have a shape.

The body fluid sensor 110 includes a carbon nanotube (CNT) 112 hybrid sensor electrode on which boron doped diamond (BDD) 111 is fixed to the surface Carbon nanotube (CNT) hybrid sensor electrode in which boron doped diamond (BDD) is fixed on the surface of the user is infiltrated into the skin of the user at a depth of 2 to 5 mm .

SUMMARY OF THE INVENTION The present invention has been made to solve the above problems of the prior art and provides a pilot bio-signal detection system using a wearable continuous blood glucose check system in which a pilot can easily wear the bio- The bio-signal abnormality of the pilot such as blood sugar or blood alcohol concentration is continuously checked to detect the occurrence of the abnormal situation beforehand, and it is possible to promptly and proactively cope with the warning by warning.

In order to make accurate measurement, the tip of the flexible probe sensor is positioned in subcutaneous (S) by sequentially passing epidemis (E) and dermis (D) of the user's skin in an oblique direction Thus, it is possible to perform efficient and accurate measurement, and it is possible to maintain the inserted state in the user's body without any external fixing means, and to avoid feeling a foreign body or pain.

On the other hand, for more precise measurement, it is possible to measure more precisely with shallow penetration depth by using carbon nanotube (CNT) hybrid sensor electrode on which boron doped diamond (BDD: Boron Doped Diamond) is fixed on the surface As a matter of course, it is possible to increase the convenience of the user.

1 is a block diagram showing a configuration of a system for detecting a bio-signal of a pilot using a wearable continuous body fluid check system according to an embodiment of the present invention;
2 is a view showing an invasive state of a flexible probe sensor of a pilot bio-signal detection system using a wearable continuous fluid inspection system according to an embodiment of the present invention;
3: A carbon nanotube (CNT: Boron Doped Diamond) deposited on the surface of a boron-doped diamond (BDD) of a pilot bio-signal detection system using a wearable continuous body fluid check system according to an embodiment of the present invention Tube) hybrid sensor electrode.
FIG. 4 is a graph showing the results of a carbon nanotube (CNT: carbon nanotube (CNT)) deposited on a surface of a boron doped diamond (BDD) of a pilot biological signal detection system using a wearable continuous body fluid check system according to an embodiment of the present invention. Tube) Hybrid sensor Electron microscope photograph showing the structure of electrode.
FIG. 5 is a graph showing the results of a carbon nanotube (CNT: carbon nanotube (CNT)) deposited on a boron doped diamond (BDD) surface of a pilot bio-signal detection system using a wearable continuous body fluid check system according to an embodiment of the present invention. A more magnified electron micrograph showing the composition of a hybrid sensor electrode.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT Hereinafter, a pilot bio-signal detection system using a wearable continuous body fluid check system according to an embodiment of the present invention will be described in detail with reference to the accompanying drawings. First, it should be noted that, in the drawings, the same components or parts are denoted by the same reference numerals whenever possible. In describing the present invention, a detailed description of known functions and configurations incorporated herein will be omitted so as to avoid obscuring the subject matter of the present invention.

As shown in FIG. 1, the system for detecting a bio-signal of a pilot using the wearable continuous fluid detection system of the present invention includes a wearable continuous body fluid check system 100 to be worn by a user, And a driving means system (200).

First, the wearable continuous fluid check system 100 will be described. The wearable continuous body fluid check system 100 is configured to be worn by a user including the pilot in the form of a small portable device or a smart watch. As shown in FIG. 1, A body fluid sensor 110 configured to include at least one of a probe sensor that is partially inserted or a surface sensor that contacts a body fluid discharged from a user's body surface; And a blood glucose measurement unit 120 for continuously measuring blood glucose levels. In this case, the blood glucose measuring unit 120 uses the body fluid of the user provided through the body fluid sensor 110 to immobilize the reversibly reactive glucose antibody on the surface thereof and to remove the glucose molecules from the reversible reactive glucose antibody and the body fluid And a non-labeled sensor that detects the generated signal. Since the configuration and operation principle of the continuous blood glucose measurement sensor unit 100 including the non-tagged sensor are described in detail in a number of prior art documents including Patent Document 1 and Patent Document 2, detailed description thereof will be omitted do. Meanwhile, when the body fluid sensor 110 is configured to include the surface sensor contacting the body fluid discharged from the body surface of the user, the body fluid of the user to be contacted may include sweat or tears. In this case, it is preferable that the surface sensor is installed so that the body fluid such as sweat or tears can be attached to or contact with the body part of the user. In other words, the wearer can be attached in the form of a separate sensor patch. In addition, when the wearable continuous body fluid check system 100 is worn in the form of a portable device or a smart watch, Or may be provided at the contact portion.

In the case where the body fluid sensor 110 comprises a probe sensor partially inserted into the user's skin, the body fluid sensor 110 is preferably a flexible probe sensor made of a material having elasticity. In this case, the flexible probe sensor 110 sequentially passes the epidemis (E) and the dermis (D) of the user's skin in an oblique direction as shown in FIG. 2, Is characterized in that its distal end is located in a subcutaneous tissue (S) in which capillary blood circulating through which blood is formed is well distributed. That is, when the flexible probe sensor 110 is made of a flexible material having elasticity, when the flexible probe sensor 110 is slowly inserted into the user's skin in the diagonal direction, the epidemis E, The flexible probe sensor 110 can be inserted in the form of a gentle curve as shown in FIG. 2 depending on the dermis (D) and the strength of the subcutaneous tissue and the characteristics of the tissue structure.

As described above, in order to further ensure that the flexible probe sensor 110 is inserted with a gentle curve as indicated by a dotted line "c" in FIG. 2, It is preferable to be formed so as to have a shape that has a curved shape with a predetermined curvature toward the outer direction in advance as shown in Fig. With this configuration, there is an advantage that the user can feel the foreign body feeling or pain while maintaining the inserted state in the user's body without any external fixing means.

In another embodiment where the body fluid sensor 110 is a probe sensor, the body fluid sensor 110 includes a boron-doped diamond (BDD) 111 as shown in FIG. 3, And a carbon nanotube (CNT) 112 hybrid sensor electrode.

Diamond, which is a quaternary semiconductor element such as silicon, is an ultra-high-speed device material having a charge transfer speed of three times that of silicon and 4.5 times that of GaAs (gallium alsenide). The basic impedance of a sensor electrode made of gold or platinum The impedance of the carbon nanotube (CNT) hybrid sensor electrode structure in which the boron doped diamond (BDD) 111 is fixed on the surface is in the range of 1,000 to 3,200 Ω, . Therefore, they have extremely sensitive and efficient detection characteristics.

On the other hand, as shown by the red and the lines in Table 1, the effective electrode area (electrode area) is much larger than that of a conventional carbon nanotube (CNT) single substance sensor or a boron doped diamond (BDD) ), So that the sensitivity and the measurement limit are extremely excellent as shown in Table 2.

In addition, as shown in Table 3 below, it has superior sensitivity and measurement limit compared to existing electrodes of various other materials.

As described above, the carbon nanotube (CNT) hybrid sensor electrode on which the boron-doped diamond (BDD) is fixed on the surface has a high sensitivity and a minimum detection limit, It is possible to perform sufficient measurement even if the depth of the user's skin is invaded only by a depth of about 2 to 5 mm at a depth of 10 mm or more. In addition, by reducing the depth of the penetration, the capillary length of the probe sensor can be reduced. As a result, fast reaction time and short settling time can be expected. In addition, despite the shortened sensing time, More accurate measurement becomes possible.

Next, the main control unit 140 will be described. 1, the main control unit 140 determines whether the blood glucose level measured by the blood glucose measurement unit 120 is out of a normal range, connected to the blood glucose measurement unit 120, A warning is displayed through the warning unit 150 when the blood glucose abnormality is out of the normal range. When a warning is displayed through the warning unit 150 as described above, the user (pilot) can appropriately perform the appropriate response such as taking food that can supplement the blood sugar as described above, It is possible to prevent a dangerous situation such as a seizure, a seizure, a shock, or loss of consciousness in advance.

1, the main control unit 140 includes a wireless communication interface 160 configured to enable wireless communication according to a universal local wireless communication standard such as Wi-Fi or Bluetooth, And also transmits the abnormality of the blood glucose status to the wireless communication interface 160. In other words, the user aboard the driving means on which the driving means system 200 is mounted as described later, while the driving means does not use the ordinary wireless communication network in accordance with the characteristics thereof but a special communication network (for example, In the case of an aircraft flying or in the case of a ship operating on the high seas). In addition, even in the case of an onshore driving means capable of using a common communication network, wireless communication is often difficult to be smoothly performed depending on the environment of a moving speed or a moving position. Accordingly, the wearable continuous body fluid check system 100, which is manufactured to be relatively small so as to be worn, can sufficiently communicate with the vehicle means system 200 mounted on the traveling means being traveling together The wireless communication with the control server 300 or the like located outside can be performed by using the operating unit communication unit 230 installed in the operating means as will be described later .

In order to be able to measure the blood alcohol concentration of a user who is fatal to safety during operation by using the characteristic that the body fluid of the user can be stably and continuously used for measurement through the body fluid sensor 110, As shown in FIG. 1, the continuous body fluid check system 100 further includes an in-body alcohol concentration measuring unit 130 that continuously measures the blood alcohol concentration in the body fluid provided through the body fluid sensor 110 desirable.

In this case, when it is determined that the blood alcohol concentration measured by the in-vivo alcohol concentration measuring unit 130 is equal to or higher than the reference value, the main control unit 140 displays a warning through the warning unit 150, It is preferable to further inform the communication interface 160 of whether or not the alcohol concentration is abnormal. In the actual operation of the pilot bio-signal detection system 10 using the wearable continuous fluid check system of the present invention, the pilot's blood alcohol concentration check function using the wearable continuous fluid check system 100 is used to wear Type continuous body fluid check system 100 to be worn by all pilots is obligatory, so that it is possible to conduct the pre-flight drunk test, which is performed only for the persons who are randomly selected irregularly at present, , It can also play a major role in preventing the drunkenness of the airplane pilot during flight that is occurring in the dark.

1, in order to measure an electrocardiogram or a heartbeat of a pilot or the like, an electrocardiogram sensor 170 capable of measuring the electrocardiogram of the user, And a pulse rate sensor 180 for measuring a heart rate of the user or a heart rate sensor 180 for measuring a heart rate vibration of the user. The main controller 140 may be configured to measure the electrocardiogram measured by the electrocardiogram sensor 170 or the pulse sensor 180, It is preferable to display a warning through the warning unit 150 and to further inform the wireless communication interface 160 whether the electrocardiogram or heartbeat abnormality is present or not Do.

The electrocardiogram sensor 170 comprises two or more electrodes capable of contacting the skin of the pilot. The electrocardiogram is an abbreviation of ECG (ElectroCardioGram). The excitation of the myocardium that moves in the atrium and ventricle in the sinus is depicted as a graph of the heart's activity current derived from an arbitrary two points in the human body. . The electrocardiogram obtained by this method is not only a diagnosis of heart disease, but also very important data such as diagnosis of various arrhythmia or electrolyte abnormality such as angina pectoris such as angina pectoris or myocardial infarction, . In this case, the electrocardiogram sensor 170 may be installed under the main body of the smartwatch when the wearable continuous fluid monitoring system 100 is configured as a smart watch.

The pulsation sensor 180 may contact the body of the pilot, and may sense the vibration according to the heartbeat of the pilot and convert the pulse into an electric signal. Macular Blue refers to the waveform of changes in pressure and volume of the vascular system and veins based on the physical changes of the heart. For this, the pulse sensor 180 may be implemented as a kind of transducer means for detecting the pulse wave vibration and converting it into an electric signal. Meanwhile, when the wearable continuous fluid monitoring system 100 is configured in the form of a Smart Watch, the pulsatile sensor 180 is worn on a part of the wrist where the pulse of the pilot can be efficiently measured, So that efficient measurement can be achieved.

Next, the traveling means system 200 will be described. As shown in FIG. 1, the driving means system 200 is installed in the driving means and receives the blood glucose abnormal state, the alcohol concentration And a driving unit control unit 230 receiving the abnormal condition, the electrocardiogram, or the occurrence of the abnormal heartbeat condition.

In the meantime, when the abnormal situations occur, the driving means system 200 controls whether or not an abnormal situation is received from the driving means control unit 230 through the communication network to the control server 300 And a driving unit communication unit 220 for transmitting the driving unit communication unit. In this case, as described above, the driving unit communication unit 220 transmits the communication standard used for the communication between the moving vehicle and the control station (for example, when the vehicle is an airplane, the air traffic control communication (ATC), air navigation management communication (AOC), air service communication (AAC), and air traffic control (APC)).

In addition, as shown in FIG. 1, in a case where the abnormal situation occurs, the driving means system 200 is controlled by the driving means control unit 230 so that the driving means can automatically cope with the operation of the driving means An auto-pilot device 240 (for example, an auto-pilot device in the case of an aircraft) for automatically controlling the driving means or an emergency driving device 250 for stopping the driving of the driving means safely For example, an automatic stopping device in the case of a train / a device for preventing start-up in a state before the start of a vehicle, etc.).

In the foregoing, optimal embodiments have been disclosed in the drawings and specification. Although specific terms have been employed herein, they are used for purposes of illustration only and are not intended to limit the scope of the invention as defined in the claims or the claims. Therefore, those skilled in the art will appreciate that various modifications and equivalent embodiments are possible without departing from the scope of the present invention. Accordingly, the true scope of the present invention should be determined by the technical idea of the appended claims.

10: Pilot bio-signal detection system using wearable continuous fluid check system
100: Wearable continuous fluid check system
110: body fluid sensor
120: blood glucose measuring unit
130: blood alcohol concentration measuring unit
140:
150: Warning section
160: Wireless communication interface
170: Electrocardiogram sensor
180: pulse sensor
200: Driving Means System
210: means of operation wireless communication interface
220: Department of Transportation
230: Driving Means
240: Autopilot
250: Emergency operation device
300: control server

Claims (7)

A body fluid sensor 110 configured to be worn by a user and configured to include a probe sensor partially inserted into the skin of a user, a blood glucose meter 110 for continuously measuring blood glucose levels in the body fluid provided through the body fluid sensor 110, And a warning unit 150 for determining if the blood glucose level measured by the blood glucose measurement unit 120 is out of a normal range and if the blood glucose level is out of the normal range, And a main controller (140) for displaying a warning via the wireless communication interface (160) and informing the wireless communication interface (160) of the abnormal blood glucose status.
And a driving means control unit (230) installed in the driving means and receiving the occurrence of the abnormality in blood glucose status from the wireless communication interface (160) through wireless communication through the driving means wireless communication interface (210) System 200; And a control unit,
The body fluid sensor 110 is composed of a carbon nanotube (CNT) 112 hybrid sensor electrode on which a boron-doped diamond (BDD) 111 is fixed on the surface as a probe sensor (10) using the wearable continuous fluid check system.
The method according to claim 1,
The wearable continuous body fluid check system 100 further comprises an in-body alcohol concentration measuring unit 130 for continuously measuring the blood alcohol concentration in the body fluid provided through the body fluid sensor 110,
If it is determined that the blood alcohol concentration measured by the in-vivo alcohol concentration measuring unit 130 is equal to or higher than the reference value, the main control unit 140 displays a warning through the warning unit 150, 160) is further informed of the presence or absence of the alcohol concentration abnormality in the alcohol concentration monitoring system (10) using the wearer's continuous body fluid check system.
The method according to claim 1,
The wearable continuous body fluid check system (100)
The electrocardiogram sensor according to claim 1, further comprising an electrocardiogram sensor (170) for measuring the electrocardiogram of the user or a pulse sensor (180) for measuring heartbeat vibration of the user,
The main control unit 140 analyzes the electrocardiogram signal or the pulse signal measured by the electrocardiogram sensor 170 or the pulse sensor 180 and determines whether the electrocardiogram or heart rate abnormality is detected Wherein the controller displays a warning and further informs the wireless communication interface (160) whether the electrocardiogram or heartbeat abnormality is present.

The method according to any one of claims 1 to 3,
The driving means system (200)
A driving unit communication unit 220 for transmitting to the control server 300 through the communication network whether or not the abnormal situation is received from the driving unit control unit 230; (10) using the wearable continuous body fluid check system (1).
The method according to claim 4,
The driving means system (200)
(240) for automatically controlling the driving means under the control of the driving means control unit (230) or the emergency driving apparatus (250) for stopping the driving of the driving means safely when the abnormal situation occurs (10). The system for detecting a bio-signal of a pilot using a wearable continuous body fluid check system according to claim 1, further comprising:
The method according to claim 1,
The body fluid sensor 110 includes a flexible probe sensor made of a material having elasticity as a probe sensor,
The flexible probe sensor is configured such that its distal end is positioned in a subcutaneous S by sequentially passing through epidemis (E) and dermis (D) of a user's skin in an oblique direction Lt; / RTI &
Wherein the flexible probe sensor is formed to have a curved shape with a predetermined curvature toward the outside when the flexible probe sensor is inserted into the user's skin.
delete

Images